Literature DB >> 20113983

Renal transplant recipient infected with Penicillium marneffei.

Jiun-Nong Lin1, Hsi-Hsun Lin, Chung-Hsu Lai, Jiun-Ling Wang, Tsan-Jung Yu.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20113983     DOI: 10.1016/S1473-3099(10)70005-0

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


× No keyword cloud information.
  6 in total

1.  Two Unusual Cases of Human Immunodeficiency Virus-Negative Patients with Talaromyces marneffei Infection.

Authors:  Ye Qiu; Mingqi Pan; Jianquan Zhang; Xiaoning Zhong; Yu Li; Hui Zhang; Bixun Li
Journal:  Am J Trop Med Hyg       Date:  2016-06-06       Impact factor: 2.345

2.  Transplantation in the tropics: lessons on prevention and management of tropical infectious diseases.

Authors:  Ligia C Pierrotti; Camille N Kotton
Journal:  Curr Infect Dis Rep       Date:  2015-07       Impact factor: 3.725

3.  In vitro interactions of calcineurin inhibitors with conventional antifungal agents against the yeast form of Penicillium marneffei.

Authors:  Dongdong Mo; Xin Li; Lili Wei; Chenghang Sun; Hao Liang; Cunwei Cao
Journal:  Mycopathologia       Date:  2014-07-23       Impact factor: 2.574

4.  Concurrent infection with Talaromyces marneffei and Cryptococcus neoformans in a patient without HIV infection.

Authors:  Susu He; Dongqing Lv; Youzu Xu; Xiaomai Wu; Ling Lin
Journal:  Exp Ther Med       Date:  2019-11-07       Impact factor: 2.447

5.  Diffuse interstitial and multiple cavitary lung lesions due to Talaromyces marneffei infection in a non-HIV patient.

Authors:  H R Li; N L Xu; M Lin; X L Hu; J H Chen; Y S Chen; S X Cai
Journal:  New Microbes New Infect       Date:  2015-07-03

Review 6.  Talaromyces (Penicillium) marneffei infection in non-HIV-infected patients.

Authors:  Jasper F W Chan; Susanna K P Lau; Kwok-Yung Yuen; Patrick C Y Woo
Journal:  Emerg Microbes Infect       Date:  2016-03-09       Impact factor: 7.163

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.